FDA Adverse Event Malfunction Summary report: N

I-STAT CHEM8+ CARTRIDGE

MDR report key: 19568885 · Received June 19, 2024

Report

Report Number
2245578-2024-00120
Event Type
Malfunction
Date Received
June 19, 2024
Date of Event
June 12, 2024
Report Date
August 7, 2024
Manufacturer
ABBOTT POINT OF CARE
Product Code
JPI
PMA / PMN Number
K183680
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT: # (B)(4). THE INVESTIGATION WAS COMPLETED ON 07-AUG-2024. A REVIEW OF THE DEVICE HISTORY RECORD CONFIRMED THE LOT PASSED FINISHED GOODS RELEASE CRITERIA. RETAINED CARTRIDGE TESTING MET THE ACCEPTANCE CRITERIA FOUND IN Q04.01.003 REV. AN, APPENDIX 1 - PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE, EXCEPT FOR POINTS OUTSIDE OF TOTAL ALLOWABLE ERROR (EA) LIMITS FOR IONIZED CALCIUM (ICA) IN WHOLE BLOOD (WB). ALTHOUGH NO POINTS OUTSIDE EA WERE OBSERVED IN RETURNED CARTRIDGE TESTING, AS PER Q04.01.003 REV. AN, APPENDIX 1 - PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE, A MINIMUM SAMPLE SIZE OF 17 IS REQUIRED TO DETERMINE ACCEPTANCE AGAINST EA CRITERIA; RETURNED CARTRIDGE TESTING PASSED ACCEPTANCE CRITERIA IN Q04.01.003 REV. AN, APPENDIX 1 FOR SUPPRESSED RESULTS. A DEFICIENCY HAS BEEN IDENTIFIED FOR CHEM8+ LOT H24040A AND WILL BE INVESTIGATED THROUGH QUALITY RECORD (QR) 990766.

Additional Manufacturer Narrative · 0

APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Description of Event or Problem · 0

ON (B)(6) 2024, ABBOTT POINT OF CARE (APOC) WAS CONTACTED BY A CUSTOMER REGARDING I-STAT CHEM8+ CARTRIDGE THAT YIELDED DISCREPANT POTASSIUM RESULTS ON AN 66 YEAR OLD FEMALE PATIENT WITH ATRIAL FIB, & EDEMA. THERE WAS NO ADDITIONAL PATIENT INFORMATION AT THE TIME OF THIS REPORT. RETURN PRODUCT IS NOT AVAILABLE FOR INVESTIGATION. METHOD DATE COLLECTED TESTED POTASSIUM SAMPLE I-STAT (B)(6) 2024 10:40 10:41 >9 MMOL/L VENIPUNCTURE A, I-STAT (B)(6) 2024 12:20 12:37 3.7 MMOL/L VENIPUNCTURE B. AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON THE LIMITED INFORMATION AVAILABLE THAT SUGGESTED THAT PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY. THE INVESTIGATION IS UNDERWAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
672750 I-STAT CHEM8+ CARTRIDGE CHEM8+ CARTRIDGE JPI ABBOTT POINT OF CARE NA H24040A

Patients

Seq Age Sex Outcome Treatment
1 66 YR Female